• 1. van Weeren PR, de Grauw JC. Pain in osteoarthritis. Vet Clin North Am Equine Pract 2010; 26: 619642.

  • 2. Caron JP. Intra-articular injections for joint disease in horses. Vet Clin North Am Equine Pract 2005; 21: 559573.

  • 3. Billinghurst RC. Biomarkers of joint disease. In: Robinson NE, ed. Current therapy in equine medicine 5. St Louis: Saunders, 2003; 513520.

    • Search Google Scholar
    • Export Citation
  • 4. Lotz M, Martel-Pelletier J & Christiansen C, et al. Value of biomarkers in osteoarthritis: current status and perspectives. Ann Rheum Dis 2013; 72: 17561763.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5. Borzi RM, Mazzetti I & Marcu KB, et al. Chemokines in cartilage degradation. Clin Orthop Relat Res 2004:S53S61.

  • 6. Chiu YC, Yang RS & Hsieh KH, et al. Stromal cell-derived factor-1 induces matrix metalloprotease-13 expression in human chondrocytes. Mol Pharmacol 2007; 72: 695703.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7. Kanbe K, Takagishi K, Chen Q. Stimulation of matrix metalloprotease 3 release from human chondrocytes by the interaction of stromal cell-derived factor 1 and CXC chemokine receptor 4. Arthritis Rheum 2002; 46: 130137.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8. Kanbe K, Takemura T & Takeuchi K, et al. Synovectomy reduces stromal-cell-derived factor-1 (SDF-1) which is involved in the destruction of cartilage in osteoarthritis and rheumatoid arthritis. J Bone Joint Surg Br 2004; 86: 296300.

    • Search Google Scholar
    • Export Citation
  • 9. Mazzetti I, Magagnoli G & Paoletti S, et al. A role for chemokines in the induction of chondrocyte phenotype modulation. Arthritis Rheum 2004; 50: 112122.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10. Wei L, Sun X & Kanbe K, et al. Chondrocyte death induced by pathological concentration of chemokine stromal cell-derived factor-1. J Rheumatol 2006; 33: 18181826.

    • Search Google Scholar
    • Export Citation
  • 11. Wei F, Moore DC & Li Y, et al. Attenuation of osteoarthritis via blockade of the SDF-1/CXCR4 signaling pathway. Arthritis Res Ther 2012; 14: R177.

  • 12. Xu Q, Sun XC & Shang XP, et al. Association of CXCL12 levels in synovial fluid with the radiographic severity of knee osteoarthritis. J Invest Med 2012; 60: 898901.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13. Wei L, Fleming BC & Sun X, et al. Comparison of differential biomarkers of osteoarthritis with and without posttraumatic injury in the Hartley guinea pig model. J Orthop Res 2010; 28: 900906.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14. Trumble TN, Brown MP & Merritt KA, et al. Joint dependent concentrations of bone alkaline phosphatase in serum and synovial fluids of horses with osteochondral injury: an analytical and clinical validation. Osteoarthritis Cartilage 2008; 16: 779786.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15. Shah VP, Midha KK & Findlay JW, et al. Bioanalytical method validation—a revisit with a decade of progress. Pharm Res 2000; 17: 15511557.

  • 16. Shirozu M, Nakano T & Inazawa J, et al. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF-1) gene. Genomics 1995; 28: 495500.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17. Kowalska MA, Ratajczak J & Hoxie J, et al. Megakaryocyte precursors, megakaryocytes and platelets express the HIV co-receptor CXCR4 on their surface: determination of response to stromal-derived factor-1 by megakaryocytes and platelets. Br J Haematol 1999; 104: 220229.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18. Cleary OB, Trumble TN & Merritt KA, et al. Effect of exercise and osteochondral injury on synovial fluid and serum concentrations of carboxy-terminal telopeptide fragments of type II collagen in racehorses. Am J Vet Res 2010; 71: 3340.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19. Garnero P, Ayral X & Rousseau JC, et al. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthritis Rheum 2002; 46: 26132624.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20. Poole AR. Can serum biomarker assays measure the progression of cartilage degeneration in osteoarthritis? Arthritis Rheum 2002; 46: 25492552.

  • 21. Poole AR. NIH white paper: biomarkers, the Osteoarthritis Initiative. Bethesda, Md: NIAMS News and Events, 2000.

  • 22. Felson DT, Lohmander LS. Whither osteoarthritis biomarkers? Osteoarthritis Cartilage 2009; 17: 419422.

  • 23. Lohmander LS. Markers of altered metabolism in osteoarthritis. J Rheumatol Suppl 2004; 70: 2835.

  • 24. Nelson F, Dahlberg L & Laverty S, et al. Evidence for altered synthesis of type II collagen in patients with osteoarthritis. J Clin Invest 1998; 102: 21152125.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 25. Nicholson AM, Trumble TN & Merritt KA, et al. Associations of horse age, joint type, and osteochondral injury with serum and synovial fluid concentrations of type II collagen biomarkers in Thoroughbreds. Am J Vet Res 2010; 71: 741749.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 26. Gangl M, Serteyn D & Lejeune JP, et al. A type II-collagen derived peptide and its nitrated form as new markers of inflammation and cartilage degradation in equine osteochondral lesions. Res Vet Sci 2007; 82: 6875.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 27. Poole AR. What do measurements of molecular biomarkers in different body fluids really tell us? Arthritis Res Ther 2011; 13: 110.

  • 28. Billinghurst RC, Brama PAJ & van Weeren PR, et al. Significant exercise-related changes in the serum levels of two biomarkers of collagen metabolism in young horses. Osteoarthritis Cartilage 2003; 11: 760769.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 29. Frisbie DD, Al-Sobayil F & Billinghurst RC, et al. Changes in synovial fluid and serum biomarkers with exercise and early osteoarthritis in horses. Osteoarthritis Cartilage 2008; 16: 11961204.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 30. Kim HJ, Lee YH, Kim CK. Biomarkers of muscle and cartilage damage and inflammation during a 200 km run. Eur J Appl Physiol 2007; 99: 443447.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 31. Luyten FP, Denti M & Filardo G, et al. Definition and classification of early osteoarthritis of the knee. Knee Surg Sports Traumatol Arthrosc 2012; 20: 401406.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32. Fuller CJ, Barr ARS, Dieppe PA. Variations in cartilage catabolism in different equine joints in response to interleukin-1 in vitro. Vet Rec 2001; 148: 204206.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 33. Frisbie DD, Ray CS & Ionescu M, et al. Measurement of synovial fluid and serum concentrations of the 846 epitope of chondroitin sulfate and of carboxy propeptides of type II procollagen for diagnosis of osteochondral fragmentation in horses. Am J Vet Res 1999; 60: 306309.

    • Search Google Scholar
    • Export Citation
  • 34. Brown MP, Trumble TN, Merritt KA. High-mobility group box chromosomal protein 1 as a potential inflammatory biomarker of joint injury in Thoroughbreds. Am J Vet Res 2009; 70: 12301235.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 35. Trumble TN, Scarbrough AB, Brown MP. Osteochondral injury increases type II collagen degradation products (C2C) in synovial fluid of Thoroughbred racehorses. Osteoarthritis Cartilage 2009; 17: 371374.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 36. Arai K, Tagami M & Hatazoe T, et al. Analysis of cartilage oligomeric matrix protein (COMP) in synovial fluid, serum and urine from 51 racehorses with carpal bone fracture. J Vet Med Sci 2008; 70: 915921.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 37. Fuller CJ, Barr AR & Sharif M, et al. Cross-sectional comparison of synovial fluid biochemical markers in equine osteoarthritis and the correlation of these markers with articular cartilage damage. Osteoarthritis Cartilage 2001; 9: 4955.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 38. Lettry V, Sumie Y & Mitsuda K, et al. Divergent diagnosis from arthroscopic findings and identification of CPII and C2C for detection of cartilage degradation in horses. Jpn J Vet Res 2010; 57: 197206.

    • Search Google Scholar
    • Export Citation
  • 39. Skioldebrand E, Heinegard D & Olofsson B, et al. Altered homeostasis of extracellular matrix proteins in joints of Standardbred trotters during a long-term training programme. J Vet Med A Physiol Pathol Clin Med 2006; 53: 445449.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 40. Fradette M-È, Céleste C & Richard H, et al. Effects of continuous oral administration of phenylbutazone on biomarkers of cartilage and bone metabolism in horses. Am J Vet Res 2007; 68: 128133.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 41. Piat P, Richard H & Beauchamp G, et al. In vivo effects of a single intra-articular injection of 2% lidocaine or 0.5% bupivacaine on articular cartilage of normal horses. Vet Surg 2012; 41: 10021010.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 42. Robion FC, Doize B & Boure L, et al. Use of synovial fluid markers of cartilage synthesis and turnover to study effects of repeated intra-articular administration of methylprednisolone acetate on articular cartilage in vivo. J Orthop Res 2001; 19: 250258.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 43. Celeste C, Ionescu M & Poole AR, et al. Repeated intraarticular injections of triamcinolone acetonide alter cartilage matrix metabolism measured by biomarkers in synovial fluid. J Orthop Res 2005; 23: 602610.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 44. Kim YS, Bigliani LU & Fujisawa M, et al. Stromal cell-derived factor 1 (SDF-1, CXCL12) is increased in subacromial bursitis and downregulated by steroid and nonsteroidal anti-inflammatory agents. J Orthop Res 2006; 24: 17561764.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 45. Ley C, Ekman S & Elmen A, et al. Interleukin-6 and tumour necrosis factor in synovial fluid from horses with carpal joint pathology. J Vet Med A Physiol Pathol Clin Med 2007; 54: 346351.

    • Crossref
    • Search Google Scholar
    • Export Citation

Advertisement

Concentrations of stromal cell-derived factor-1 in serum, plasma, and synovial fluid of horses with osteochondral injury

David C. DymockDepartment of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610.

Search for other papers by David C. Dymock in
Current site
Google Scholar
PubMed
Close
 BVSc
,
Murray P. BrownDepartment of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610.

Search for other papers by Murray P. Brown in
Current site
Google Scholar
PubMed
Close
 DVM, MSc
,
Kelly A. MerrittDepartment of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610.

Search for other papers by Kelly A. Merritt in
Current site
Google Scholar
PubMed
Close
 BS
, and
Troy N. TrumbleDepartment of Veterinary Population Medicine, College of Veterinary Medicine, University of Minnesota, Saint Paul, MN 55108.

Search for other papers by Troy N. Trumble in
Current site
Google Scholar
PubMed
Close
 DVM, PhD

Abstract

Objective—To determine whether stromal cell-derived factor-1 (SDF-1) concentrations in serum, plasma, and synovial fluid differed among untrained, race-trained, and osteochondral-injured Thoroughbred racehorses.

Animals—22 racehorses without osteochondral injury and 37 racehorses with osteochondral injury.

Procedures—Horses without osteochondral injury were examined before and after 5 to 6 months of race training. Horses with osteochondral injury were undergoing arthroscopic surgery for removal of osteochondral fragments from carpal or metacarpophalangeal or metatarsophalangeal joints (fetlock joints). Serum, plasma, and fetlock or carpal synovial fluid samples were obtained and analyzed for SDF-1 concentration by use of an ELISA.

Results—In horses with fetlock or carpal joint injury, mean synovial fluid SDF-1 concentrations were significantly higher, serum SDF-1 concentrations were significantly lower, and synovial fluid-to-serum SDF-1 ratios were significantly higher than in untrained and trained horses. Synovial fluid SDF-1 concentrations were not significantly different between trained and untrained horses. Plasma SDF-1 concentrations were not different among the 3 groups. Results obtained with serum, compared with synovial fluid and plasma, had better sensitivity for differentiating between osteochondral-injured horses and uninjured horses. In horses with fetlock joint osteochondral injury, serum SDF-1 concentrations were correlated with radiographic and arthroscopic inflammation scores, but not arthroscopic cartilage scores.

Conclusions and Clinical Relevance—Results suggested that serum SDF-1 concentrations were more sensitive than plasma and synovial fluid concentrations for detection of osteochondral injury in the fetlock or carpal joint of racehorses. Analysis of serum and synovial SDF-1 concentrations in horses with experimentally induced joint injury may help define the onset and progression of post-traumatic osteoarthritis and aid in the evaluation of anti-inflammatory treatments.

Abstract

Objective—To determine whether stromal cell-derived factor-1 (SDF-1) concentrations in serum, plasma, and synovial fluid differed among untrained, race-trained, and osteochondral-injured Thoroughbred racehorses.

Animals—22 racehorses without osteochondral injury and 37 racehorses with osteochondral injury.

Procedures—Horses without osteochondral injury were examined before and after 5 to 6 months of race training. Horses with osteochondral injury were undergoing arthroscopic surgery for removal of osteochondral fragments from carpal or metacarpophalangeal or metatarsophalangeal joints (fetlock joints). Serum, plasma, and fetlock or carpal synovial fluid samples were obtained and analyzed for SDF-1 concentration by use of an ELISA.

Results—In horses with fetlock or carpal joint injury, mean synovial fluid SDF-1 concentrations were significantly higher, serum SDF-1 concentrations were significantly lower, and synovial fluid-to-serum SDF-1 ratios were significantly higher than in untrained and trained horses. Synovial fluid SDF-1 concentrations were not significantly different between trained and untrained horses. Plasma SDF-1 concentrations were not different among the 3 groups. Results obtained with serum, compared with synovial fluid and plasma, had better sensitivity for differentiating between osteochondral-injured horses and uninjured horses. In horses with fetlock joint osteochondral injury, serum SDF-1 concentrations were correlated with radiographic and arthroscopic inflammation scores, but not arthroscopic cartilage scores.

Conclusions and Clinical Relevance—Results suggested that serum SDF-1 concentrations were more sensitive than plasma and synovial fluid concentrations for detection of osteochondral injury in the fetlock or carpal joint of racehorses. Analysis of serum and synovial SDF-1 concentrations in horses with experimentally induced joint injury may help define the onset and progression of post-traumatic osteoarthritis and aid in the evaluation of anti-inflammatory treatments.

Contributor Notes

Supported in part by an American College of Veterinary Surgeons Foundation Surgeon-in-Training Grant 2011.

Presented in part in abstract form at the 2012 World Congress on Osteoarthritis, Barcelona, Spain, April 2012.

Address correspondence to Dr. Brown (brownmu@ufl.edu).